Joe Lonsdale
@joe_lonsdale·85.5K subscribers·787 videos
The End of Cancer? CAR T-Cell Therapy & the Biology Revolution
Posted
April 7, 2022
Views
20,086
Likes
271
Comments
21
Engagement
1.45%
April 7, 2022
20,086
271
21
1.45%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
8:36Now Playing“The chemotherapy failed and you have six months to live.”
Denise Delatorre would never forget her doctor’s words. Multiple rounds of chemotherapy could not eliminate an aggressive form of lymphoma. The cancer had won.
That is, until she enrolled in Kite Pharma’s clinical trial for CAR T-cell therapy, a breakthrough technology that reprograms T cells (a type of white blood cell) to identify specific proteins on cancer cells and destroy them. Unlike the grueling process of chemotherapy, they simply drew her blood, reprogrammed the cells in a lab, and then injected them back into her body. Within weeks, Denise was confirmed as cancer free.
⏩ SUPPORT THE SHOW ⏪
Like this video and subscribe to the channel ➡️
She owes her recovery to a confluence of medical breakthroughs, notably gene editing, and a cast of entrepreneurs and scientists who have labored for decades to bring cell therapies to market. It's important to note that CAR T-cell therapy is not a silver bullet. It carries risks, like any innovative treatment, but has saved numerous lives and become an effective tool against previously incurable diseases.
We are fortunate to feature one of the leaders in cell therapies in this film: Dr. Jeff Bluestone, the CEO and President of Sonoma Bio. A pioneer in the field, Dr. Bluestone explains the remarkable potential of cell therapies, which are currently effective in blood cancers and may soon work against solid tumors and autoimmune disorders.
We also highlight the innovators working to bring this technology to the masses, such as Paul Dabrowski, co-founder and CEO of Synthego. Dabrowski and his team are building the bioengineering infrastructure around cell therapies so that entrepreneurs can deliver these bespoke treatments at scale and commercialize them for the general public.
Finally, we feature 8VC Partner Francisco Gimenez, who explains 8VC’s role in the biotech revolution and the unique opportunity to invest in saving lives while also building companies that will reshape medicine for generations to come.
America is in the midst of a renaissance in biological sciences that will transform medicine and improve countless lives. We are excited to share an important element of that story with the American public.
If you enjoyed this short film, check out these episodes of American Optimist:
Reprogramming Cells & the Incredible Biotech Revolution with Dr. Rick Klausner
Niall Ferguson: Why Great Civilizations Rise & Fall
For permission to use any portion of this video, please contact us at info@americanoptimist.com
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
